Clover Health Investments, Corp. (CLOV)
$
2.24
-0.03 (-1.34%)
Key metrics
Financial statements
Free cash flow per share
-0.1685
Market cap
1.2 Billion
Price to sales ratio
0.6519
Debt to equity
0
Current ratio
1.7106
Income quality
1.4508
Average inventory
0
ROE
-0.1712
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States, highlighting the company's shareholder base with a weighted average number of shares outstanding of 490,018,730.00. The company's efficiency in production and sales operations is evidenced by a gross profit ratio of 0.27 while the net income ratio of -0.03 reflects the company's profitability margin. Reporting an earnings per share (EPS) of -$0.09 it indicates Clover Health's profitability on a per-share basis, demonstrating a favorable financial outcome for its investors. Furthermore, the company reported selling, general, and administrative expenses of $408,934,000.00 which indicates its operational overhead costs and provides insight into its financial management. Incorporated in 2014 and based in Franklin, Tennessee, Clover Health utilizes its Clover Assistant software platform to offer preferred provider organization and health maintenance organization health plans tailored for Medicare-eligible consumers, while also engaging in non-insurance businesses. The stock is affordable at $3.03 making it attractive for budget-conscious investors. With a high average trading volume of 5,940,333.00 the stock showcases strong liquidity, allowing for easier transactions on the market. The company's market capitalization of $1,156,136,386.00 classifies it as a small-cap player, which can offer unique opportunities for growth. As a key player in the Medical - Healthcare Plans industry, Clover Health Investments, Corp. contributes significantly to the overall market landscape, driving innovation and growth within its sector, which belongs to the Healthcare. This strategic positioning allows Clover Health to navigate challenges while seeking to enhance its offerings and expand its market share.
Is Clover Health Investments, Corp. (CLOV) a good investment?
Investing in Clover Health Investments, Corp. (CLOV) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as D+, with a Bearish outlook. Always conduct your own research before investing.
What is Clover Health Investments, Corp. (CLOV)'s stock forecast?
Analysts predict Clover Health Investments, Corp. stock to fluctuate between $2.12 (low) and $4.80 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Clover Health Investments, Corp.'s market capitalization?
As of 2026-01-30, Clover Health Investments, Corp.'s market cap is $1,156,136,386, based on 516,132,315 outstanding shares.
How does Clover Health Investments, Corp. compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, Clover Health Investments, Corp. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Clover Health Investments, Corp. (CLOV) stock?
To buy Clover Health Investments, Corp. (CLOV) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CLOV. Place an order (Market, Limit, etc.).
What is the best time to invest in Clover Health Investments, Corp.?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
How did Clover Health Investments, Corp. perform in the last earnings report?
Revenue: $1,371,131,000 | EPS: -$0.09 | Growth: -80.49%.
Where can I find Clover Health Investments, Corp.'s investor relations reports?
Visit https://www.cloverhealth.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Clover Health Investments, Corp.?
You can explore historical data from here
What is the all-time high and low for Clover Health Investments, Corp. stock?
All-time high: $11.13 (2021-09-07) | All-time low: $0.61 (2024-04-22).
What are the key trends affecting Clover Health Investments, Corp. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
seekingalpha.com
Clover Health Investments is now a contrarian buy, with the market underestimating its path to profitability in 2026. CLOV's member retention exceeds 90%, older cohorts generate $217 monthly profit, and the Clover Assistant AI is driving clinical and financial improvements. The stock trades at less than 0.5x 2026 sales, with a fair value estimate of $3.30 per share—28% above current levels.
zacks.com
Clover Health shows strong membership growth, rising revenues and sustained EBITDA gains from Clover Assistant, though near-term margin pressure remains a risk.
seekingalpha.com
Clover Health Investments, Corp. (CLOV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
zacks.com
Clover Health posts 53% AEP PPO membership growth, lifts total members to 153,000, and says the momentum positions it for GAAP net income profitability in 2026.
globenewswire.com
SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Counterpart Health , Inc. (“Counterpart” or the “Company”), a leading AI-powered physician-enablement platform and subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV), today released key 2025 highlights. The past year was defined by continued publication of research demonstrating the platform's impact on chronic disease management, meaningful product expansion, and the scaled adoption of Counterpart Assistant (CA) by hundreds of live third-party customer clinicians across diverse practice settings.
zacks.com
Clover Health shows strong membership growth, rising revenues and sustained EBITDA gains from Clover Assistant, though near-term margin pressure remains a risk.
seekingalpha.com
Clover Health Investments, Corp. (CLOV) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
zacks.com
Clover Health Investments (CLOV) reported earnings 30 days ago. What's next for the stock?
seekingalpha.com
Despite disappointing YTD earnings due to higher than expected medical costs, Clover's expected GAAP profitability in 2026 marks a critical inflection point. Clover's higher returning member mix and targeted growth measures aiming to bring more members under Clover Assistant quicker are major tailwinds to medical costs next year, in my opinion. Clover Assistant's early diagnosis capabilities set the company up to benefit from the CMS' Part D measures aiming to normalize cost pressures on plans, in my opinion.
seekingalpha.com
Clover Health Investments, Corp. ( CLOV ) UBS Global Healthcare Conference 2025 November 11, 2025 11:00 AM EST Company Participants Peter Kuipers - Chief Financial Officer Presentation Unknown Analyst Okay. All right.
See all news
